Our Technology

Innovative Design Space for Therapeutics

Our technology platform involves an innovative design space to robustly develop therapeutics with the desired product profile (for new drugs) or a comprehensive equivalence framework (for generics). This design space is created using a proprietary data science platform that combines structure-guided molecular design, diverse and orthogonal analytical technologies (chemistry and bioassays), and machine learning tools to learn from these diverse data sets to ensure successful convergence to a clinically successful product.

​

Our technology platform is also built on a robust regulatory science-based framework that combines multiple synergistic analytical and functional measurements to establish robust correlations between i) the critical structural attributes of the drug ii) the process conditions and the product attributes and iii) the product attributes and appropriate readouts capturing the drug safety and efficacy profiles.